dysmenorrhoea. Primary dysmenorrhoea
Conditions
Interventions
Intervention 1: Capsule of Zinc acetate (30mg) daily for3 days from beginning of menstruation for two consecutive cycles. Intervention 2: One capsule of placebo (Avicil PH110) daily for 3 days from be
Treatment - Drugs
Placebo
Capsule of Zinc acetate (30mg) daily for3 days from beginning of menstruation for two consecutive cycles
One capsule of placebo (Avicil PH110) daily for 3 days from beginning of menstruation for two consecutive cycles
Sponsors
Vice Chancellor for Research, Islamic Azad Univercity, Falavarjan Branch
Eligibility
Sex/Gender
Female
Age
18 Years to 25 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Single18 to25 years old students, intensity of pain was4 and more by visual analogue scale (VAS) , normal cycle (duration of cycle21-35 , bleeding3-7 days) , no history of abdominal or pelvic surgery or any specific disease such as hepatic, renal and cardiac diseases, diabetes, presence of secondary dysmenorrhea, non consumption of oral contraceptive pills in two months ago, no stressful condition in3 months ago and during the study like death of family members. Exclusion criteria: Improper administration of the medication, administration of contraceptive pills or another medication whilst on research, severe stress, not to consent to continue the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dismenorrhea. Timepoint: One month before the intervention and two months after the intervention. Method of measurement: Visual Analogue Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarzieh Javanmardi
Islamic Azad Univercity, Falavarjan Branch
Outcome results
None listed